LeMaitre Vascular (NSDQ:LMAT) recently issued an urgent field safety notice for some of its Syntel Silicone over-the-wire embolectomy catheters. The Burlington, Massachusetts-based company issued the warning due to the French size next to the outside diameter symbol on the label not reflecting the 5 Fr catheter extrusion used on all models of … [Read more...] about LeMaitre Vascular warns on some Syntel Silicone over-the-wire embolectomy catheters
LeMaitre Vascular
LeMaitre Vascular grows sales 10% in Q1 results
Lemaitre Vascular (NSDQ:LMAT) posted first-quarter results that beat the revenue consensus on Wall Street and missed earnings estimates. The Burlington, Massachusetts-based vascular device company reported profits of $6 million, or 27¢ per share on sales of $39.6 million for the three months ended March 31, for a bottom-line gain of 1.8% on … [Read more...] about LeMaitre Vascular grows sales 10% in Q1 results
LeMaitre Vascular beats The Street in Q4, grows sales 5%
LeMaitre Vascular (NSDQ:LMAT) posted fourth-quarter results that beat the overall consensus forecast on Wall Street. The Burlington, Massachusetts-based company yesterday evening reported profits of $6.2 million, or 28¢ per share, on sales of $39.5 million for the three months ended Dec. 31, 2021, for a bottom-line loss of -12.2% on sales growth … [Read more...] about LeMaitre Vascular beats The Street in Q4, grows sales 5%
LeMaitre profits up 86% in Q1 results
LeMaitre Vascular (NSDQ:LMAT) posted first-quarter results yesterday that beat the consensus on Wall Street. The company reported profits of $5.9 million, or 28¢ per share, on sales of $35.8 million, for the three months ended March 31, for a bottom-line gain of 86.8% sales growth of 17.45% compared with Q1 2020. Get the full story on our … [Read more...] about LeMaitre profits up 86% in Q1 results
LeMaitre Vascular grows 25% in Q4
LeMaitre Vascular yesterday posted fourth-quarter results that beat the consensus forecast on Wall Street. The Burlington, Mass.-based company report profits of $7 million, or 34¢ per share, on sales of $37.5 million for the three months ended Dec. 31, 2020, for a bottom-line gain of 52.5% on sales growth of 24.5% compared with Q4 … [Read more...] about LeMaitre Vascular grows 25% in Q4
The worst catheter-based device recalls of 2020
The U.S. saw nine serious medical device recalls related to catheters in 2020 — up from four the previous year, according to the FDA. The agency 2020 tagged a total of 33 medical device recalls as Class I — the most serious level — down from 49 in 2019. The list of the most serious catheter-based device recalls in 2020 includes products from … [Read more...] about The worst catheter-based device recalls of 2020
LeMaitre Vascular up on Street-beating Q3 results
LeMaitre Vascular (NSDQ:LMAT) posted third-quarter results that beat the consensus forecast on Wall Street. The Burlington, Mass.-based company reported profits of $7.5 million, or 37¢ per share, on sales of $36.4 million for the three months ended Sept. 30, for a bottom-line gain of 44.9% sales growth of 25.1% compared with Q3 2019. Get the … [Read more...] about LeMaitre Vascular up on Street-beating Q3 results
LeMaitre Vascular recall of embolectomy catheters is Class I
The FDA identified the recall of LeMaitre Vascular (NSDQ:LMAT) Over the Wire embolectomy catheters for a failure to deflate as a Class I recall. Burlington, Mass.–based LeMaitre Vascular's Over the Wire embolectomy catheter is indicated for use in the surgical removal of blood clots that are lodged in a blood vessel (emboli) and blood clots that … [Read more...] about LeMaitre Vascular recall of embolectomy catheters is Class I
